Phase II Trial of RC1416 Injection in Asthma

Clinical trial NCT07403487 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07403487
Sponsor: Nanjing RegeneCore Biotech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Asthma

Start date: 2026-03-10
Primary completion: 2027-10-25
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.